Members Login
Channels
Special Offers & Promotions
Spinnovation points stem cell culture in the right direction
Spinnovation,
the NMR profiling experts, have produced a detailed case study
examining the utility of NMR profiling methodology to monitor and
optimise stem cell culture media, for the production of biologics and
cells for therapeutic purpose. For more information please visit http://bit.ly/SPIcasestudy
Today, cell culture and particularly stem cell culture is facing a number of challenges including new FDA edicts on defined media, feeder strategy and media optimisation methodology. "Stem cell culture presents a number of challenges at the current time, with the new regulatory demands of defined media. As a result, the industry needs reliable technology to monitor and optimise stem cell bioproduction in order to identify the critical cell media components for optimal stem cell growth and viability, and for the control of cell differentiation. This will be critical for delivering upstream process efficiency with consistent quality" said Frederic Girard the CEO of Spinnovation. "I believe that Spedia-NMRTM profiling can provide the monitoring and optimisation technology the stem cell industry needs to provide success in bringing new clinical products to market".
have developed Spedia-NMRTM, a NMR profiling technology, to monitor stem cell cultures throughout bioprocessing allowing the media recipe to be optimised for the most efficient and reproducible production of stem cells.
For further information, please visit: www.spinnovation-biologics.com
Today, cell culture and particularly stem cell culture is facing a number of challenges including new FDA edicts on defined media, feeder strategy and media optimisation methodology. "Stem cell culture presents a number of challenges at the current time, with the new regulatory demands of defined media. As a result, the industry needs reliable technology to monitor and optimise stem cell bioproduction in order to identify the critical cell media components for optimal stem cell growth and viability, and for the control of cell differentiation. This will be critical for delivering upstream process efficiency with consistent quality" said Frederic Girard the CEO of Spinnovation. "I believe that Spedia-NMRTM profiling can provide the monitoring and optimisation technology the stem cell industry needs to provide success in bringing new clinical products to market".
have developed Spedia-NMRTM, a NMR profiling technology, to monitor stem cell cultures throughout bioprocessing allowing the media recipe to be optimised for the most efficient and reproducible production of stem cells.
For further information, please visit: www.spinnovation-biologics.com
Media Partners